Evidence map›Paper›PMID 40718775›Full record

ArticlePeerJ2025

Pengyu Wang, Junxiu Lu, Min Wang, Guangming Wang, Huaqiu Chen

Abstract read
In one paragraph

Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. International journal of molecular sciences · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pengyu Wang *School of Clinical Medicine, Dali University, Dali, Yunnan Province, China.
Junxiu LuSchool of Clinical Medicine, Dali University, Dali, Yunnan Province, China.
Min WangSchool of Clinical Medicine, Dali University, Dali, Yunnan Province, China.
Guangming WangSchool of Clinical Medicine, Dali University, Dali, Yunnan Province, China.
Huaqiu Chen *Clinical Laboratory, Xichang People's Hospital, Xichang, Sichuan Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ischemic stroke (IS) is a major health concern in the Chinese population. Previous studies have highlighted the role of NRF2 in IS. This study investigates the association between NRF2 polymorphisms and IS susceptibility in a Chinese population. Methods: This retrospective study included Chinese patients diagnosed with IS based on clinical symptoms, neurological examinations, and brain imaging findings from computed tomography or magnetic resonance imaging. Age- and sex-matched unrelated individuals with no family history of stroke, tumors, or genetic diseases served as controls. Peripheral blood samples were collected to genotype seven single-nucleotide polymorphisms (SNPs) in NRF2 (rs13005431, rs4893819, rs6721961, rs35652124, rs6726395, rs2364723, rs2706110) using the SNaPshot method. Binary logistic regression analysis was used to assess associations between these SNPs and IS risk. NRF2 and reactive oxygen species (ROS) levels in peripheral blood were measured. The relationship between rs35652124 and NRF2 expression was evaluated using expression quantitative trait locus (eQTL) analysis. Results: All seven NRF2 SNPs conformed to Hardy-Weinberg equilibrium. Six SNPs (rs13005431, rs4893819, rs6721961, rs6726395, rs2364723, and rs2706110) showed no significant differences in distribution between the case and control groups ( Conclusion: The NRF2 rs35652124 polymorphism is associated with IS susceptibility, suggesting it may be a potential genetic risk factor for IS.

Indexed as

Genetic Predisposition to DiseaseIschemic StrokeNF-E2-Related Factor 2Polymorphism, Single NucleotideAgedCase-Control StudiesChinaEast Asian PeopleFemaleGenotypeHumansMaleMiddle AgedReactive Oxygen SpeciesRetrospective StudiesNFE2L2 protein, humanNF-E2-Related Factor 2Reactive Oxygen SpeciesChinese populationIschemic strokeNRF2Single-nucleotide polymorphismSusceptibility

Identifiers

PMID40718775
PMCPMC12296571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.